Machida H, Inoue S, Shibata Y, Kimura T, Sato K, Abe K, Murano H, Yang S, Nakano H, Sato M, Nemoto T, Sato C, Nishiwaki M, Yamauchi K, Igarashi A, Tokairin Y, Watanabe M. Thymus and activation-regulated chemokine (TARC/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease. Allergology International. 202101; 70(1):81-88.
Shirai T, Tanino Y, Nikaido T, Takaku Y, Hashimoto S, Taguchi Y, Baba T, Ogura T, Kataoka K, Nakayama M, Yamada Y, Matsushima S, Nakayama S, Miyazaki Y. Screening and diagnosis of acute and chronic bird related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmnoCAP®. Allergology International. 202104; 70(2):208-214.
Gono T, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Ikeda K, Kirino Y, Sugiyama Y, Tanino Y, Nunokawa T, Kaneko Y, Sato S, Asakawa K, Ukichi T, Kaieda S, Naniwa T, Okano Y, Kuwana M; the Multicenter Retrospective Cohort of Japanese Patients with Myositis-Associated ILD (JAMI) Investigators. Risk stratification modeling based on a combination of initial serum biomarkers in myositis-associated interstitial lung disease: JAMI risk score. Arthritis & Rheumatology. 202104; 73(4):677-686.
Sakamoto S, Kataoka K, Kondo Y, Kato M, Hoshino T, Mukae H, Bando M, Suda T, Kido T, Tanino Y, Kishaba T, Hattori N, Taguchi Y, Saitoh T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F, Homma S, Homma S; Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan. Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomized trial. European Respiratory Journal. 202101; 57(1):2000348.
Kawashima Y, Harada T, Fujita Y, Nakagawa T, Watanabe K, Morikawa N, Takamura K, Kanazawa K, Kuda T, Usui K, Sekine A, Inoue A, Sugawara S. Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302. International Journal of Clinical Oncology. 202103; 26(3):515-522.
Machida H, Inoue S, Shibata Y, Kimura T, Ota T, Ishibashi Y, Murano H, Furuyama K, Yang S, Nakano H, Sato K, Sato M, Nemoto T, Nishiwaki M, Yamauchi K, Igarashi A, Watanabe M. The incidence and risk analysis of lung cancer development in patients with chronic obstructive pulmonary disease: Possible effectiveness of annual ct-screening. International Journal of Chronic Obstructive Pulmonary Disease. 202103; 16:739-749.
Mori H, Ohkawara H, Togawa R, Rikimaru M, Shibata Y, Ikezoe T. Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review. International Journal of Hematology. 202103; 113(3):320-329.
Anan K, Kataoka Y, Okabayashi S, Yamamoto R, Namkoong H, Yamamoto Y. Diagnostic accuracy of Aspergillus-specific antibodies for chronic pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses. 202107; 64(7):701-715.
Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y. Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study. Journal of Asthma and Allergy. 202104; 14:325-334.
COVID-19 Host Genetics Initiative(Shibata Y, Tanino Y, Sato Y, et al). Mapping the human genetic architecture of COVID-19. Nature. 202112; 600(7889):472.
Sakaue S, Yamaguchi E, Inoue Y, Takahashi M, Hirata J, Suzuki K, Ito S, Arai T, Hirose M, Tanino Y, Nikaido T, Ichiwata T, Ohkouchi S, Hirano T, Takada T, Miyawaki S, Dofuku S, Maeda Y, Nii T, Kishikawa T, Ogawa K, Masuda T, Yamamoto K, Sonehara K, Tazawa R, Morimoto K, Takaki M, Konno S, Suzuki M, Tomii K, Nakagawa A, Handa T, Tanizawa K, Ishii H, Ishida M, Kato T, Takeda N, Yokomura K, Matsui T, Watanabe M, Inoue H, Imaizumi K, Goto Y, Kida H, Fujisawa T, Suda T, Yamada T, Satake Y, Ibata H, Hizawa N, Mochizuki H, Kumanogoh A, Matsuda F, Nakata K, Hirota T, Tamari M, Okada Y. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis. Nature Communications. 202102; 12(1):1032.
Matsunaga K, Kuwahira I, Hanaoka M, Saito J, Tsuburai T, Fukunaga K, Matsumoto H, Sugiura H, Ichinose M, Japanese Respiratory Society Assembly on Pulmonary Physiology. An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice. Respiratory investigation. 202101; 59(1):34-52.
Mukae H, Kaneko T, Obase Y, Shinkai M, Katsunuma T, Takeyama K, Terada J, Niimi A, Matsuse H, Yatera K, Yamamoto Y, Azuma A, Arakawa H, Iwanaga T, Ogawa H, Kurahashi K, Gon Y, Sakamoto H, Shibata Y, Tamada T, Nishioka Y, Haranaga S, Fujieda S, Miyashita N, Mochizuki H, Yokoyama A, Yoshihara S, Tamaoki J. The Japanese respiratory society guidelines for the management of cough and sputum (digest edition). Respiratory Investigation. 202105; 59(3):270-290.
Hisata S, Bando M, Homma S, Kataoka K, Ogura T, Izumi S, Sakamoto S, Watanabe K, Saito Y, Shimizu Y, Kato M, Nishioka Y, Hara H, Waseda Y, Tanino Y, Yatera K, Hashimoto S, Mukae H, Inase N; Diffuse Lung Diseaeses Research Group of the Ministry of Health, Labor and Welfare, Japan. Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: a multicenter retrospective observational study in Japan. Respiratory Investigation. 202111; 59(6):819-826.
Watanabe K, Toi Y, Nakamura A, Chiba R, Akiyama M, Sakakibara-Konishi J, Tanaka H, Yoshimura N, Miyauchi E, Nakagawa T, Igusa R, Minemura H, Mori Y, Fujimoto K, Matsushita H, Takahashi F, Fukuhara T, Inoue A, Sugawara S, Maemondo M; North Japan Lung Cancer Study Group, Sendai, Japan. Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001. Translational Lung Cancer Research. 202102; 10(2):712-722.
Shibata Y, Muro S, Yokoyama A, Hashimoto S. Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic. Respiratory Investigation. 202107; 59(4):385-388.
Suzuki Y, Tanino Y, Nikaido T, Minemura H, Umeda T, Rikimaru M, Onuma T, Naito S, Takiguchi Y, Tomita H, Kawamata T, Togawa R, Sato Y, Uematsu M, Morimoto J, Kitakawa K, Tsukada Y, Nakamura K, Kanemitsu K, Iseki K, Shibata Y. Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin. Internal Medicine. 202102; 60(3):457-461.
英文総説
Suzuki Y, Saito J, Munakata M, Shibata Y. Hydrogen sulfide as a novel biomarker of asthma and chronic obstructive pulmonary disease. Allergology International. 202104; 70(2):181-189.
Kawamata T, Tanino Y, Nikaido T, Sato Y, Togawa R, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Rikimaru M, Suzuki Y, Minemura H, Saito J, Kanazawa K, Shibata Y. Efficacy of concurrent administration of tocilizumab with corticosteroids for patients with COVID-19. 25th Congress of the APSR; 20211120; Kyoto.
Nikaido T, Tanino Y, Sato Y, Togawa R, Kawamata T, Fukuhara N, Yamada R, Fujii R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Umeda T, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Shibata Y. Clinical significance of serum heart-type fatty acid-binding protein (H-FABP) in acute exacerbation of idiopathic interstitial pneumonias. 25th Congress of the APSR; 20211120; Kyoto.
Rikimaru M, Saito J, Suzuki Y, Fukuhara A, Tanino Y, Shibata Y. The time course of type 2 biomarkers in asthmatics treated with dupilumab. 25th Congress of the APSR; 20211120; Kyoto.
Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Fukuhara N, Fuji R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Umeda T, Suzuki Y, Minemura H, Saito J, Kanazawa K, Shibata Y. High incidence of MPO-ANCA positive interstitial pneumonia during the COVID-19 pandemic. 25th Congress of the APSR; 20211120; Kyoto.
Suzuki Y, Saito J, Rikimaru M, Fukuhara A, Kawamata T, Togawa R, Sato Y, Nikaido T, Fukuhara N, Tanino Y, Shibata Y. Clinical application of serum and sputum YKL-40 in Asthma, ACO and COPD. 25th Congress of the APSR; 20211120; Kyoto.
